Bird Flu > Bird Flu News > USPTO issues patent related to Seattle Genetics' ADC technology (News-Medical-Net)

USPTO issues patent related to Seattle Genetics' ADC technology (News-Medical-Net)
Seattle Genetics, Inc. announced today that the U.S. Patent and Trademark Office has issued a patent related to its antibody-drug conjugate (ADC) technology. U.S. Patent No. 7,659,241 covers cleavable linkers and potent auristatin drug payloads used in certain of Seattle Genetics’ ADC programs, most notably brentuximab vedotin (SGN-35), as well as many ADC programs in development by its ...